China Resources Pharmaceutical Group Ltd3320
▲ ポジティブ資本関連度
China Resources Pharmaceutical's subsidiary plans to acquire a 23.50% stake in Lier Chemical, expanding its portfolio.
銘柄への影響 3
Biotech & Genomic Medicine
China Resources Pharmaceutical Group Ltdその他
Lier Chemical Co Ltd002258
▲ ポジティブ資本関連度
Lier Chemical is the target of a 23.50% stake acquisition by China Resources Double-Crane, likely boosting its valuation.
China Resources Double-Crane Pharmaceutical Co Ltd600062
▲ ポジティブ資本関連度
China Resources Double-Crane is the direct acquirer of a 23.50% stake in Lier Chemical, a strategic investment.
テーマインパクト
カバレッジ外企業 2
Sichuan Jiuyuan Investment Holding Group Co Ltd非上場± 混在
関連度
四川化材科技有限公司非上場± 混在
関連度